0001567619-19-017605.txt : 20190827 0001567619-19-017605.hdr.sgml : 20190827 20190827171955 ACCESSION NUMBER: 0001567619-19-017605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190823 FILED AS OF DATE: 20190827 DATE AS OF CHANGE: 20190827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Radov A. Jeffrey CENTRAL INDEX KEY: 0001528040 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37603 FILM NUMBER: 191058432 MAIL ADDRESS: STREET 1: 8 WALWORTH AVENUE CITY: SCARSDALE STATE: NY ZIP: 10583 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioRestorative Therapies, Inc. CENTRAL INDEX KEY: 0001505497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 911835664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 760-8100 MAIL ADDRESS: STREET 1: 40 MARCUS DRIVE CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: Stem Cell Assurance, Inc. DATE OF NAME CHANGE: 20101110 4 1 doc1.xml FORM 4 X0306 4 2019-08-23 0 0001505497 BioRestorative Therapies, Inc. BRTX 0001528040 Radov A. Jeffrey 8 WALWORTH AVENUE SCARSDALE NY 10583 1 0 0 0 Common Stock 2019-08-23 4 P 0 3000 0.2632 A 15500 D Common Stock 2019-08-26 4 P 0 3000 0.25 A 18500 D Stock Option .75 2022-02-09 Common Stock 30000 30000 D Stock Option .75 2022-12-07 Common Stock 5000 5000 D Stock Option .75 2023-10-04 Common Stock 12500 12500 D Stock Option .75 2024-02-18 Common Stock 25000 25000 D Stock Option .75 2024-10-23 Common Stock 50000 50000 D Stock Option .75 2025-09-04 Common Stock 115500 115500 D Stock Option .75 2026-06-10 Common Stock 128000 128000 D Stock Option .75 2027-06-23 Common Stock 125000 125000 D Stock Option .75 2028-10-29 Common Stock 75000 75000 D The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013. The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018. The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. /s/ A. Jeffrey Radov 2019-08-27